Ouragins

Ouragins

Early Stage

tech scrubs that turn customers into shareholders

tech scrubs that turn customers into shareholders

Overview

Raised to Date: Raised: $146,312

Total Commitments ($USD)

Platform

Rialto Markets

Start Date

02/13/2022

Close Date

04/03/2022

Min. Goal
$10,000
Max. Goal
$500,000
Min. Investment

$147

Security Type

Equity - Common

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$1.47

Pre-Money Valuation

$12,791,768

Rolling Commitments ($USD)

Status
Funded
Reporting Date

04/29/2022

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$3,048

# of Investors

43

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Logos provided by Clearbit
Year Founded

2020

Industry

Apparel & Fashion

Tech Sector

HealthTech

Distribution Model

B2C

Margin

Medium

Capital Intensity

Low

Location

El Monte, California

Business Type

Growth

Company Website

Ouragins, with a valuation of $12.7 million, is raising funds on Rialto Markets. The company makes science-backed scrubs using antimicrobial tech fabrics. The fabrics of Ouragins scrubs are soft, breathable, come with 4-way stretch, and move seamlessly with the customers. Ouragins is led by an experienced team and has been featured in Yahoo, Men’s Health, and Business Insider. Shaun Veran founded Ouragins in July 2020. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $500,000. The campaign proceeds will be used for product development, tech and data science, sales and marketing, and new hires.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$800

$0

 

 

Net Income

$-632

$0

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$4,096

$252

Accounts Receivable

$0

$0

Total Assets

$225,110

$202,929

Short-Term Debt

$742

$2,929

Long-Term Debt

$0

$0

Total Liabilities

$742

$2,929
Financials as of: 02/13/2022
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Ouragins 04/29/2023 Rialto Markets $18,935,379 - Equity - Common Funded RegCF
Ouragins 04/02/2022 Rialto Markets $12,791,768 $146,312 Equity - Common Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Valuation History

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Ouragins on Rialto Markets 2022
Platform: Rialto Markets
Security Type: Equity - Common
Valuation: $12,791,768
Price per Share: $1.47

Follow company

Follow Ouragins on Rialto Markets 2022
View on Rialto Markets (Closed)
Deal Analytics
Company Ratings
Deal Considerations

Buy Ouragins's Deal Report

Warning: according to the close date for this deal, Ouragins may no longer be accepting investments.

Ouragins Deal Report

Get KingsCrowd’s comprehensive report on Ouragins including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Ouragins is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Ouragins deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge